1. Home
  2. HAIN vs IMUX Comparison

HAIN vs IMUX Comparison

Compare HAIN & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

N/A

Current Price

$1.18

Market Cap

99.6M

ML Signal

N/A

Logo Immunic Inc.

IMUX

Immunic Inc.

N/A

Current Price

$0.59

Market Cap

85.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAIN
IMUX
Founded
1993
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.6M
85.8M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
HAIN
IMUX
Price
$1.18
$0.59
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
$2.91
$6.00
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
11-07-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,533,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.56
52 Week High
$7.96
$1.39

Technical Indicators

Market Signals
Indicator
HAIN
IMUX
Relative Strength Index (RSI) 53.79 33.23
Support Level $1.00 $0.58
Resistance Level $1.24 $0.70
Average True Range (ATR) 0.06 0.04
MACD 0.02 -0.01
Stochastic Oscillator 77.12 3.55

Price Performance

Historical Comparison
HAIN
IMUX

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: